Doctor profile · Federal record
Dr. ZONERA ALI, MD
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · WYNNEWOOD, PA
- NPI 1306852728
- Accepts Medicare
- MIPS 97.3 / 100 · 2023
- 31 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
100 E LANCASTER AVE
WYNNEWOOD, PA 190963450
(610) 645-2494
fax (610) 645-4456 - Mailing address
-
100 LANCASTER AVE, MAIN LINE ONCOLOGY HEMATOLOGY ASSOCIATES
WYNNEWOOD, PA 19096
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- September 3, 2019
- Year of graduation
- 1995 — 31 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Pennsylvania #MD0070583L
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1306852728. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
50,431
Distinct HCPCS
10
Medicare allowed
$365,798
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 41,250 | 21 | $1 | |
J0897 |
Injection, denosumab, 1 mg | 4,320 | 21 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,672 | 24 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 860 | 15 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 804 | 331 | $135 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 249 | 177 | $96 | |
96367 |
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 201 | 26 | $31 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 197 | 28 | $141 | |
96372 |
Injection of drug or substance under skin or into muscle | 169 | 37 | $15 | |
96375 |
Injection of additional new drug or substance into vein | 163 | 25 | $17 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 1,539. This provider delivers 33× the peer median.Open Payments
Industry payments received
All-time total
$3,431
Transactions
113
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $446.62 | |
| Novartis Pharmaceuticals Corporation | 14 | $293.54 | |
| Astellas Pharma US Inc | 11 | $264.50 | |
| Eisai Inc. | 11 | $250.90 | |
| Lilly USA, LLC | 9 | $198.22 | |
| ABBVIE INC. | 9 | $197.17 | |
| GENZYME CORPORATION | 5 | $194.31 | |
| Genentech USA, Inc. | 7 | $183.41 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $128.59 | |
| PFIZER INC. | 5 | $118.70 | |
| Janssen Biotech, Inc. | 4 | $108.90 | |
| Alexion Pharmaceuticals, Inc. | 2 | $106.24 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $91.09 | |
| Gilead Sciences, Inc. | 3 | $79.17 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69.09 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
843
Patients
159
Total drug cost
$1,285,849
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 239 | 53 | $6,187 |
| Tamoxifen Citrate | Generic | 132 | 24 | $2,407 |
| Anastrozole | Generic | 90 | 22 | $2,168 |
| Exemestane | Generic | 71 | 18 | $14,915 |
| Eliquis (Apixaban) | Brand | 50 | 0 | $43,433 |
| Lenalidomide | Generic | 32 | 0 | $385,899 |
| Xarelto (Rivaroxaban) | Brand | 31 | 0 | $26,834 |
| Gabapentin | Generic | 30 | 0 | $338 |
| Prednisone | Generic | 30 | 11 | $267 |
| Ondansetron Hcl | Generic | 25 | 18 | $196 |